Tanvex Accelerates CDMO Layout to Expand Business Opportunities Jun.28,2023 Jul.08,2024 獲美上市許可後 泰福再叩關第二張藥證 Read More Oct.04,2021 FDA Accepts TX05 BLA Filing Read More May.16,2023 Tanvex BioPharma Enters Exclusive Distribution Agreement for Nypozi (filgrastim) in Canada Read More